Drug recall · August 21, 2019
Clotrimazole and Betamethasone Dipropionate Cream USP recall
Why: Temperature Abuse: Complaints received of liquidy texture.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%, 15 gram tubes, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Village: Kishanpura, Baddi Nalagarth Road, District: Solan, Himachal Pradesh-173205, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-298-17
- Lots / codes
Lot #: 05180734, Exp. 03/2020
- Quantity
- 31,224 tubes
- Company
- Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ
- Distribution
- Nationwide with the United States
- Initiated
- August 7, 2019 · Voluntary: Firm initiated
- Classified
- August 15, 2019
- Reported
- August 21, 2019
- Ended
- November 9, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clotrimazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.